Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Study highlights lack of data on transgender leukemia patients

Key clinical point: Gender-karyotype mismatches can identify transgender patients but some of these patients may be overlooked.

Major finding: Of the all the patients analyzed, 0.3% had a gender-karyotype mismatch.

Study details: Data from 1,748 patients with acute myeloid leukemia or myelodysplastic syndromes enrolled in five Southwest Oncology Group (SWOG) trials.

Disclosures: Dr. Alpert and her colleagues did not disclose any conflicts of interest. The Acute Leukemia Forum is organized by Hemedicus, which is owned by the same company as this news organization.